Tempus PurIST
RNA-based algorithmic classifier of basal-like versus classical pancreatic ductal adenocarcinoma subtype.
- Developer
- Tempus AI
- Intended use
- Diagnostic Aid
- Cancer scope
- Pancreatic cancer
- Specimen
- FFPE tumor tissue
- Molecular modality
- RNA expression
- Current version
- Current Tempus PurIST RNA-based algorithmic LDT (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.